Talis Biomedical (TLIS)
(Real Time Quote from BATS)
$4.26 USD
+0.12 (2.90%)
Updated Aug 16, 2024 01:28 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
TLIS 4.26 +0.12(2.90%)
Will TLIS be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for TLIS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for TLIS
Amicus Therapeutics (FOLD) Reports Q1 Loss, Tops Revenue Estimates
Halozyme Therapeutics (HALO) Q1 Earnings and Revenues Miss Estimates
TLIS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for TLIS
Crude Oil Jumps Over 3%; Upstart Shares Spike Higher
Nasdaq Jumps 250 Points; Disney Earnings Beat Estimates
Why Is Talis Biomedical (TLIS) Stock Down 52% Today?
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Why Fortinet Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket